Getting started with high-throughput mass spectrometry in early drug discovery | |||||
Wed10 Nov11:00am(30 mins)
|
![]() |
Dr Martin Bachman | |||
Session : Emerging Discovery Strategies
Room: Auditorium
|
Assist Plus | |||||
Tue9 Nov11:45am(5 mins)
|
![]() |
![]() |
Ms Sharon Barnard | ||
Session : Hit Triage
Room: Helix Room
|
Using DiBT-MS for high throughput and novel biocatalyst pharmaceutical discovery | |||||
Wed10 Nov09:10am(50 mins)
|
![]() |
![]() |
Perdita Barran | ||
Session : Keynote Presentation
Room: Auditorium
|
Pragmatic screening collection refinement to facilitate hit progression | |||||
Tue9 Nov04:05pm(30 mins)
|
![]() |
![]() |
Dr Kristian Birchall | ||
Session : Hit Triage
Room: Helix Room
|
Reactive fragment screening for expansion of the liganded proteome | |||||
Wed10 Nov02:00pm(30 mins)
|
![]() |
![]() |
Jacob Bush | ||
Room: Helix Room
|
Case studies in cellular nuisance compounds | |||||
Tue9 Nov11:50am(30 mins)
|
![]() |
![]() |
Dr Jayme Dahlin | ||
Session : Hit Triage
Room: Helix Room
|
Right assay, right hit, right time. Identify “more physiological hits” earlier in drug discovery | |||||
Tue9 Nov03:35pm(30 mins)
|
![]() |
Mrs Kathy Dodgson | |||
Session : Emerging Discovery Strategies
Room: Auditorium
|
Patient-derived cell models as a clinically-relevant drug discovery strategy | |||||
Tue9 Nov04:05pm(30 mins)
|
![]() |
|
Gareth Griffiths | ||
Session : Emerging Discovery Strategies
Room: Auditorium
|
Building a high-throughput MS workflow for covalent Hit Finding | |||||
Wed10 Nov10:30am(30 mins)
|
![]() |
Dr Sarah Hewitt | |||
Room: Helix Room
|
New way of screening: A case study comparing an iterative screening approach to conventional HTS campaigns. | |||||
Wed10 Nov02:00pm(30 mins)
|
![]() |
|
Markus Hierl | ||
Session : Emerging Discovery Strategies
Room: Auditorium
|
CDD Vault - Complexity Simplified | |||||
Tue9 Nov02:30pm(5 mins)
|
![]() |
![]() |
Miss Tamsin Lamont | ||
Session : Emerging Discovery Strategies
Room: Auditorium
|
Computational and Empirical Strategies to Triage Nuisance Compounds in HTS | |||||
Tue9 Nov02:35pm(30 mins)
|
![]() |
Scott Maidment | |||
Session : Hit Triage
Room: Helix Room
|
An Introduction of the Medicines Discovery Catapult | |||||
Tue9 Nov02:30pm(5 mins)
|
![]() |
![]() |
Dr Martin Main | ||
Session : Hit Triage
Room: Helix Room
|
Bioluminescent Tools & Approaches for RAS Pathway Drug Discovery | |||||
Tue9 Nov10:15am(15 mins)
|
![]() |
![]() |
Dr Craig Malcolm | ||
Session : Keynote Presentation
Room: Auditorium
|
An update on the JUMP-CP Consortium: insights from pilot experiments and outlook | |||||
Tue9 Nov11:15am(30 mins)
|
![]() |
![]() |
Paula A. Marin-Zapata | ||
Session : Emerging Discovery Strategies
Room: Auditorium
|
Computational and Empirical Strategies to Triage Nuisance Compounds in HTS | |||||
Tue9 Nov02:35pm(30 mins)
|
|
Sarah Martin | |||
Session : Hit Triage
Room: Helix Room
|
Developing assay development tools to make screening less PAINS-full | |||||
Tue9 Nov02:00pm(30 mins)
|
![]() |
![]() |
Dr Stuart McElroy | ||
Session : Hit Triage
Room: Helix Room
|
Application of Acoustic Mist Ionisation MS to rapidly identify hits with undesirable mechanisms of action in HTS outputs | |||||
Tue9 Nov11:15am(30 mins)
|
![]() |
![]() |
Dr Rachel Moore | ||
Session : Hit Triage
Room: Helix Room
|
The concept of G-quadruplex ligands as novel gene regulators and potential anticancer drugs | |||||
Tue9 Nov02:35pm(30 mins)
|
![]() |
![]() |
Stephen Neidle | ||
Session : Emerging Discovery Strategies
Room: Auditorium
|
Identification of allosteric binders of an active GPCR : Screening of EDELRIS Keymical Space™ by Affinity Selection-Mass Spectrometry | |||||
Wed10 Nov02:30pm(30 mins)
|
![]() |
![]() |
Mr Renaud Prudent | ||
Room: Helix Room
|
Modernising Drug Design and Prioritisation with AI | |||||
Wed10 Nov10:30am(30 mins)
|
![]() |
Simon Richards | |||
Session : Emerging Discovery Strategies
Room: Auditorium
|
MALDI-TOF AS-MS – a label-free hit validation strategy in early drug discovery | |||||
Wed10 Nov11:15am(15 mins)
|
![]() |
![]() |
Dr Roman Simon | ||
Room: Helix Room
|
R&D at the New Speed of Science - Accelerate your R&D Transformation with Benchling | |||||
Tue9 Nov11:45am(5 mins)
|
![]() |
Jonathan Stone | |||
Session : Emerging Discovery Strategies
Room: Auditorium
|
Hit or Miss? The Importance of Triage in the Active to Hit Transition | |||||
Tue9 Nov03:35pm(30 mins)
|
![]() |
![]() |
Alexandra Stowell | ||
Session : Hit Triage
Room: Helix Room
|
A MALDI-TOF assay identifies nilotinib as an inhibitor of inflammation in acute myeloid leukaemia | |||||
Wed10 Nov02:30pm(30 mins)
|
![]() |
![]() |
Prof Matthias Trost | ||
Session : Emerging Discovery Strategies
Room: Auditorium
|
Revolutionizing Screening: MALDI-ToF Mass Spectrometry in a Fully Automated HTS System | |||||
Wed10 Nov01:30pm(30 mins)
|
![]() |
![]() |
Dr Steven van Helden | ||
Room: Helix Room
|
Utilizing biophysics to kick start drug discovery projects | |||||
Wed10 Nov11:00am(15 mins)
|
![]() |
![]() |
Dr Jana Wolf | ||
Room: Helix Room
|